T1	Subject 1141 1149	patients
T5	Anatomical_entity 1186 1191	Serum
T10	Disorder 1395 1398	IPF
T12	GGPs 643 663	surfactant protein A
T13	Disorder 1009 1012	IPF
T16	GGPs 665 669	SP-A
T17	Anatomical_entity 1652 1657	serum
T21	Subject 692 703	35 patients
T25	Disorder 1465 1468	IPF
T26	Subject 483 491	patients
T27	Cell 579 600	alveolar type II cell
T28	GGPs 1240 1261	lactate dehydrogenase
T29	Artificial_process 1325 1347	corticosteroid therapy
T30	Subject 746 757	17 patients
T31	GGPs 456 460	FasL
T33	Disorder 1281 1284	IPF
T37	Pathway 210 220	signalling
T42	Disorder 709 738	idiopathic pulmonary fibrosis
T43	Entity_Property 1155 1163	inactive
T52	Anatomical_entity 472 477	serum
T53	Disorder 1618 1621	IPF
T54	Subject 987 995	patients
T55	Method_cue 912 917	ELISA
T57	Subject 91 99	patients
T59	Pathway 274 281	pathway
T60	GGPs 610 630	surfactant protein D
T61	GGPs 632 636	SP-D
T67	Anatomical_entity 1439 1444	serum
T79	Disorder 1699 1702	IPF
T82	Anatomical_entity 681 686	serum
T85	Cellular_process 200 209	apoptosis
T87	Entity_Property 1050 1058	inactive
T88	Subject 1479 1487	patients
T89	Disorder 740 743	IPF
T90	Anatomical_entity 933 938	serum
E2	Artificial_process:T29 
E4	Pathway:T37 
E6	Pathway:T59 
E12	Cellular_process:T85 
N1	Reference T1 UMLS:C0030705	Patients
N17	Reference T5 UMLS:C0229671	Serum
N26	Reference T10 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N34	Reference T12 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
N37	Reference T13 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N51	Reference T17 UMLS:C0229671	Serum
N60	Reference T21 UMLS:C0030705	Patients
N81	Reference T25 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N83	Reference T26 UMLS:C0030705	Patients
N86	Reference T27 UMLS:C0225700	Type-II Pneumocytes
N89	Reference T28 UMLS:C0022917	Lactate Dehydrogenase
N91	Reference E2 UMLS:C0149783	Steroid therapy
N92	Reference T30 UMLS:C0030705	Patients
N100	Reference T33 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N114	Reference E4 UMLS:C3537152	biological signaling
N126	Reference T42 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N129	Reference T43 UMLS:C0544452	Disease remission
N157	Reference T52 UMLS:C0229671	Serum
N158	Reference T53 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N161	Reference T54 UMLS:C0030705	Patients
N164	Reference T55 UMLS:C0014441	Enzyme-Linked Immunosorbent Assay
N167	Reference T57 UMLS:C0030705	Patients
N181	Reference T60 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N188	Reference T61 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N209	Reference T67 UMLS:C0229671	Serum
N246	Reference T79 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N259	Reference T82 UMLS:C0229671	Serum
N266	Reference E12 UMLS:C0162638	Apoptosis
N270	Reference T87 UMLS:C0544452	Disease remission
N272	Reference T88 UMLS:C0030705	Patients
N274	Reference T89 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N281	Reference T90 UMLS:C0229671	Serum
T101	Disorder 105 128	fibrosing lung diseases
N24	Reference T101 UMLS:C0034069	Pulmonary Fibrosis
T102	Disorder 321 344	fibrosing lung diseases
N27	Reference T102 UMLS:C0034069	Pulmonary Fibrosis
T103	Disorder 497 520	fibrosing lung diseases
N28	Reference T103 UMLS:C0034069	Pulmonary Fibrosis
T20	Disorder 763 785	interstitial pneumonia
N2	Reference T20 UMLS:C0206061	Pneumonia, Interstitial
T93	Disorder 1021 1023	IP
N4	Reference T93 UMLS:C0206061	Pneumonia, Interstitial
T94	Disorder 1476 1478	IP
N5	Reference T94 UMLS:C0206061	Pneumonia, Interstitial
T2	Disorder 802 828	collagen vascular diseases
T23	Pathway 146 175	Fas-Fas ligand (FasL) pathway
E11	Pathway:T23 Participant:T58 Participant2:T113
T81	GGPs 446 450	sFas
T98	GGPs 547 551	sFas
T99	GGPs 1445 1449	sFas
T100	GGPs 462 467	sFasL
T104	GGPs 553 558	sFasL
T105	GGPs 949 954	sFasL
T106	GGPs 1120 1125	sFasL
T107	GGPs 1192 1197	sFasL
T108	GGPs 1302 1307	sFasL
T109	GGPs 1658 1663	sFasL
T110	GGPs 560 564	KL-6
N48	Reference T110 UMLS:C0057628	Mucin-1 protein
T111	GGPs 1266 1270	KL-6
N50	Reference T111 UMLS:C0057628	Mucin-1 protein
N45	Reference T16 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
T112	Method_cue 876 910	enzyme-linked immunosorbent assays
N53	Reference T112 UMLS:C0014441	Enzyme-Linked Immunosorbent Assay
T3	GGPs 441 444	Fas
N8	Reference T3 UMLS:C0245662	CD95 Antigens
N9	Reference T81 UMLS:C0245662	CD95 Antigens
N13	Reference T98 UMLS:C0245662	CD95 Antigens
N15	Reference T99 UMLS:C0245662	CD95 Antigens
N30	Reference T100 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
N32	Reference T104 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
N33	Reference T105 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
N35	Reference T106 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
N36	Reference T107 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
N38	Reference T108 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
N39	Reference T109 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
T14	GGPs 40 50	Fas ligand
N40	Reference T14 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
T50	Subject 843 845;853 869	13 healthy controls
N42	Reference T50 UMLS:C2986479	Healthy Control
T9	Subject 1071 1079	controls
N25	Reference T9 UMLS:C0009932	Control Groups
T62	Subject 1176 1184	controls
N44	Reference T62 UMLS:C0009932	Control Groups
T68	Subject 1492 1500	controls
N46	Reference T68 UMLS:C0009932	Control Groups
R1	Subject_Disorder Arg1:T57 Arg2:T101	
R2	Subject_Disorder Arg1:T26 Arg2:T103	
R3	Subject_Disorder Arg1:T21 Arg2:T42	
R4	Subject_Disorder Arg1:T30 Arg2:T20	
R5	Subject_Disorder Arg1:T54 Arg2:T13	
T76	Subject 1479 1487	patients
N49	Reference T76 UMLS:C0030705	Patients
R6	Subject_Disorder Arg1:T88 Arg2:T25	
T77	Subject 1582 1590	patients
N55	Reference T77 UMLS:C0030705	Patients
R7	Subject_Disorder Arg1:T77 Arg2:T53	
T45	Gene_expression 939 945	levels
E7	Gene_expression:T45 Theme:T105 atLoc:T90
N41	Reference E7 UMLS:C1519614	Genetic Translation Process
T66	Gene_expression 22 28	levels
E9	Gene_expression:T66 Theme:T14
N57	Reference E9 UMLS:C1519614	Genetic Translation Process
N58	Reference E11 UMLS:C3546404	Fas-FasL signaling pathway
T58	GGPs 146 149	Fas
N59	Reference T58 UMLS:C0245662	CD95 Antigens
N7	Reference T31 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
T113	GGPs 150 160	Fas ligand
N61	Reference T113 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
T114	GGPs 162 166	FasL
N63	Reference T114 UMLS:C0253023	Tumor Necrosis Factor Ligand Superfamily Member 6
T116	Positive_regulation 0 9	Increased
E14	Positive_regulation:T116 Theme:E9 disorder:T101
N68	Reference E14 UMLS:C1879547	Activation action
T117	Positive_regulation 974 983	increased
E15	Positive_regulation:T117 Theme:E7 disorder:T13
N70	Reference E15 UMLS:C1879547	Activation action
T118	Negative_regulation 1290 1298	decrease
E16	Negative_regulation:T118 Theme:E19 Cause:E2
N72	Reference E16 UMLS:C3463820	Inhibition
T119	Subject 987 995	patients
N73	Reference T119 UMLS:C0030705	Patients
T63	Biological_process 305 317	pathogenesis
E17	Biological_process:T63 Theme:T102
N74	Reference E17 UMLS:C0699748	Pathogenesis
T120	Positive_regulation 974 983	increased
E18	Positive_regulation:T120 disorder:T91 disorder2:T93 Theme:E7
N75	Reference E18 UMLS:C1879547	Activation action
T121	Gene_expression 1308 1314	levels
E19	Gene_expression:T121 Theme:T108
N76	Reference E19 UMLS:C1519614	Genetic Translation Process
T40	Subject 1582 1590	patients
N77	Reference T40 UMLS:C0030705	Patients
T122	Disorder 1629 1631	IP
N79	Reference T122 UMLS:C0206061	Pneumonia, Interstitial
T44	Correlation 289 297	involved
E20	Correlation:T44 Theme:E6 Theme2:E17 Cue:T35 Cue2:T22
T38	Disorder 834 836	IP
N14	Reference T38 UMLS:C0206061	Pneumonia, Interstitial
N12	Reference T2 UMLS:C0262428	Collagen-vascular disease
T48	Disorder 830 833	CVD
N16	Reference T48 UMLS:C0262428	Collagen-vascular disease
T65	Disorder 1711 1713	IP
N19	Reference T65 UMLS:C0206061	Pneumonia, Interstitial
R14	Disorder_association Arg1:T20 Arg2:T2	
R15	Disorder_association Arg1:T48 Arg2:T38	
T91	Disorder 1017 1020	CVD
N3	Reference T91 UMLS:C0262428	Collagen-vascular disease
T92	Disorder 1472 1475	CVD
N10	Reference T92 UMLS:C0262428	Collagen-vascular disease
T95	Disorder 1625 1628	CVD
N20	Reference T95 UMLS:C0262428	Collagen-vascular disease
T96	Disorder 1707 1710	CVD
N23	Reference T96 UMLS:C0262428	Collagen-vascular disease
R16	Disorder_association Arg1:T91 Arg2:T93	
R17	Disorder_association Arg1:T92 Arg2:T94	
R18	Disorder_association Arg1:T95 Arg2:T122	
R19	Disorder_association Arg1:T96 Arg2:T65	
R20	Subject_Disorder Arg1:T76 Arg2:T92	
R23	Subject_Disorder Arg1:T40 Arg2:T95	
R24	Subject_Disorder Arg1:T119 Arg2:T91	
R9	Subject_Disorder Arg1:T30 Arg2:T2	
R10	Subject_Disorder Arg1:T119 Arg2:T93	
R25	Subject_Disorder Arg1:T76 Arg2:T94	
R27	Subject_Disorder Arg1:T40 Arg2:T122	
T15	Biological_process 601 607	damage
E3	Biological_process:T15 Theme:T27
N62	Reference E6 UMLS:C0037080	Signal Pathways
N6	Reference E20 UMLS:C0332281	Associated with
T7	Correlation 1224 1234	correlated
E1	Correlation:T7 Theme:T107 Theme2:T28 Theme3:T111 disorder:T33
N21	Reference E1 UMLS:C0332281	Associated with
T24	Speculation_cue 538 546	measured
T22	Speculation_cue 282 285	may
T35	Speculation_cue 253 263	determined
N43	Reference E3 UMLS:C0010957	Tissue damage
T39	Disorder 1059 1066	disease
N47	Reference T39 UMLS:C0012634	Disease
A1	Speculated E20
R29	part_of Arg1:T52 Arg2:T26	
T49	Disorder 1164 1171	disease
N64	Reference T49 UMLS:C0012634	Disease
R30	Subject_Disorder Arg1:T1 Arg2:T49	
